Found this article earlier - IGF1 seems to be showing preliminary efficacy in another type of autism.
http://sfari.org/news-and-opinion/c...or-shows-promise-for-phelan-mcdermid-syndrome
Augurs well for nnz-2566.
If we can manage FDA approval for Rett, it really does open the doors across the autism spectrum - truly a class effect!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$19.83 |
Change
-0.310(1.54%) |
Mkt cap ! $2.509B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.83 | $19.80 | $10.75M | 525.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 313 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.85 | 1316 | 13 |
View Market Depth
| Last trade - 15.00pm 19/09/2025 (20 minute delay) ? |
| NEU (ASX) Chart |